Follow this preprint
Neurofilaments as blood biomarkers at the preataxic and ataxic stage of spinocerebellar ataxia type 3: a cross-species analysis in humans and mice
View ORCID ProfileCarlo Wilke, Eva Haas, View ORCID ProfileKathrin Reetz, View ORCID ProfileJennifer Faber, Hector Garcia-Moreno, View ORCID ProfileMagda M. Santana, Bart van de Warrenburg, Holger Hengel, View ORCID ProfileManuela Lima, Alessandro Filla, Alexandra Durr, View ORCID ProfileBela Melegh, Marcella Masciullo, Jon Infante, View ORCID ProfilePaola Giunti, Manuela Neumann, Jeroen de Vries, Luis Pereira de Almeida, Maria Rakowicz, Heike Jacobi, View ORCID ProfileRebecca Schüle, Stephan A. Kaeser, Jens Kuhle, Thomas Klockgether, Ludger Schöls, SCA3 neurofilament study group, European Integrated Project on Spinocerebellar Ataxias (EuroSCA/RiSCA), European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative (ESMI), Christian Barro, Jeannette Hübener-Schmid, Matthis Synofzik
doi: https://doi.org/10.1101/19011882
Now published in EMBO Molecular Medicine doi: 10.15252/emmm.201911803
Carlo Wilke
1Hertie Institute for Clinical Brain Research (HIH) and Center of Neurology, University of Tübingen, Germany
2German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Germany
Eva Haas
3Institute of Medical Genetics and Applied Genomics, University of Tübingen, Germany
4Centre for Rare Diseases, University of Tübingen, Germany
Kathrin Reetz
5Department of Neurology, RWTH Aachen University, Aachen, Germany
6JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich, RWTH Aachen University, Aachen, Germany
Jennifer Faber
7Department of Neurology, University Hospital Bonn, Bonn, Germany
8German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
Hector Garcia-Moreno
9Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology
10National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust
Magda M. Santana
11Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
Bart van de Warrenburg
12Donders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands
Holger Hengel
1Hertie Institute for Clinical Brain Research (HIH) and Center of Neurology, University of Tübingen, Germany
2German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Germany
Manuela Lima
13Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal
Alessandro Filla
14Department of Neuroscience, and Reproductive and Odontostomatological Sciences, Federico II University Naples, Naples, Italy
Alexandra Durr
15Sorbonne Université, Institut du Cerveau et de la Moelle épinière (ICM), AP-HP, Inserm, CNRS, University Hospital Pitié-Salpêtrière, Paris, France
Bela Melegh
16Department of Medical Genetics, and Szentagothai Research Center, University of Pécs Medical School, Pécs, Hungary
Marcella Masciullo
17Spinal Rehabilitation Lab (SPIRE), IRCCS Fondazione Santa Lucia, Via Ardeatina 306, 00179, Rome, Italy
Jon Infante
18Service of Neurology, University Hospital Marqués de Valdecilla (IDIVAL), University of Cantabria (UC) and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Santander, Spain
Paola Giunti
9Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology
10National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust
Manuela Neumann
2German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Germany
19Department of Neuropathology, University of Tübingen, Germany
Jeroen de Vries
20Department of Neurology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands
Luis Pereira de Almeida
11Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
Maria Rakowicz
21First Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
Heike Jacobi
8German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
22Department of Neurology, University Hospital of Heidelberg, Heidelberg
Rebecca Schüle
1Hertie Institute for Clinical Brain Research (HIH) and Center of Neurology, University of Tübingen, Germany
2German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Germany
Stephan A. Kaeser
1Hertie Institute for Clinical Brain Research (HIH) and Center of Neurology, University of Tübingen, Germany
2German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Germany
Jens Kuhle
23Neurology, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland
Thomas Klockgether
7Department of Neurology, University Hospital Bonn, Bonn, Germany
8German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
Ludger Schöls
1Hertie Institute for Clinical Brain Research (HIH) and Center of Neurology, University of Tübingen, Germany
2German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Germany
Christian Barro
23Neurology, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland
Jeannette Hübener-Schmid
3Institute of Medical Genetics and Applied Genomics, University of Tübingen, Germany
4Centre for Rare Diseases, University of Tübingen, Germany
Matthis Synofzik
1Hertie Institute for Clinical Brain Research (HIH) and Center of Neurology, University of Tübingen, Germany
2German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Germany

Data Availability
Data will be made available upon reasonable request and as patient consent allows. Data will be shared with researchers who provide a methodologically sound proposal to achieve the aims in the approved proposal. Proposals should be directed to the corresponding author. To obtain data access, data requestors will need to sign a data access agreement.
Posted November 27, 2019.
Neurofilaments as blood biomarkers at the preataxic and ataxic stage of spinocerebellar ataxia type 3: a cross-species analysis in humans and mice
Carlo Wilke, Eva Haas, Kathrin Reetz, Jennifer Faber, Hector Garcia-Moreno, Magda M. Santana, Bart van de Warrenburg, Holger Hengel, Manuela Lima, Alessandro Filla, Alexandra Durr, Bela Melegh, Marcella Masciullo, Jon Infante, Paola Giunti, Manuela Neumann, Jeroen de Vries, Luis Pereira de Almeida, Maria Rakowicz, Heike Jacobi, Rebecca Schüle, Stephan A. Kaeser, Jens Kuhle, Thomas Klockgether, Ludger Schöls, SCA3 neurofilament study group, European Integrated Project on Spinocerebellar Ataxias (EuroSCA/RiSCA), European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative (ESMI), Christian Barro, Jeannette Hübener-Schmid, Matthis Synofzik
medRxiv 19011882; doi: https://doi.org/10.1101/19011882
Now published in EMBO Molecular Medicine doi: 10.15252/emmm.201911803
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (734)
- Anesthesia (215)
- Cardiovascular Medicine (3142)
- Dermatology (267)
- Emergency Medicine (467)
- Epidemiology (13107)
- Forensic Medicine (15)
- Gastroenterology (873)
- Genetic and Genomic Medicine (4925)
- Geriatric Medicine (453)
- Health Economics (758)
- Health Informatics (3104)
- Health Policy (1110)
- Hematology (414)
- HIV/AIDS (978)
- Medical Education (459)
- Medical Ethics (121)
- Nephrology (507)
- Neurology (4685)
- Nursing (248)
- Nutrition (692)
- Oncology (2414)
- Ophthalmology (688)
- Orthopedics (270)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (522)
- Pediatrics (1254)
- Primary Care Research (526)
- Public and Global Health (7244)
- Radiology and Imaging (1619)
- Respiratory Medicine (949)
- Rheumatology (463)
- Sports Medicine (407)
- Surgery (522)
- Toxicology (65)
- Transplantation (223)
- Urology (193)